YS Biopharma Co. Ltd.

NASDAQ: YS · Real-Time Price · USD
1.02
0.09 (9.68%)
At close: May 24, 2024, 10:00 PM

YS Biopharma Balance Sheet Statement

Financials in CNY. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Cash & Equivalents
370.11M 271.07M 390.46M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
20.92M 28.23M 88.77M
Receivables
463.05M 308.56M 248.12M
Inventory
185.38M 166.51M 81.44M
Other Current Assets
10.41M 7.99M 74.51K
Total Current Assets
1.04B 764.76M 733.2M
Property-Plant & Equipment
582.89M 565M 253.45M
Goodwill & Intangibles
78.06M 80.72M 83.78M
Total Long-Term Assets
683.77M 676.99M 433.97M
Total Assets
1.72B 1.44B 1.17B
Account Payables
80.44M 30.81M 16.38M
Deferred Revenue
2.3M 2.3M 2.12M
Short-Term Debt
198.49M 116.06M 3.79M
Other Current Liabilities
377.54M 326.75M 322.75M
Total Current Liabilities
658.76M 475.91M 345.04M
Long-Term Debt
300.14M 264.53M 14.65M
Other Long-Term Liabilities
8.79M 1.37B 1.29B
Total Long-Term Liabilities
332.54M 1.66B 1.33B
Total Liabilities
991.3M 2.14B 1.68B
Total Debt
498.63M 380.59M 18.44M
Common Stock
12.3K 7.98K 7.98K
Retained Earnings
-1.87B -1.59B -1.35B
Comprehensive Income
-54.41M 83.09M 44.22M
Shareholders Equity
728.45M -698.97M -508.86M
Total Investments
n/a n/a n/a